PrEP decision support in emergency departments
Part of Infections clinical trials.
This study is testing a decision-support tool that helps emergency department patients learn about and start taking PrEP, a daily medicine that prevents HIV. If you are HIV negative and visiting the ER for a non-life-threatening issue, this study may help you access HIV prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 18 and older
- Able to speak and read English
- HIV negative (no HIV infection)
- Visiting the emergency department or urgent care and medically stable (not critically ill)
- Not currently taking PrEP or PEP medicines to prevent HIV
- Not pregnant and not taking medicines that could harm the kidneys
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study tests a program to help Black women decide whether to start PrEP (a daily pill that prevents HIV). It aims to make it easier to get PrEP and support your health.
This study is testing whether starting PrEP (daily pills to prevent HIV) right away in the emergency department helps people at high risk for HIV. It aims to make it easier to start protection before you leave the hospital.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
This study tests a simple online tool to help young people decide whether PrEP (a daily pill that prevents HIV) might be right for them. The tool uses information from an at-home HIV test and is designed to make PrEP information easier to understand.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.